SME Times is powered by   
Search News
Just in:   • PLI scheme has attracted Rs 1.46 lakh crore investment, created 9.5 lakh jobs  • India’s growth momentum has picked up after Q2 slowdown: Jeffries  • Centre pays Rs 4,820 crore to 2.75 lakh farmers for pulses under MSP scheme  • India needs economically-viable tech for infra projects: Nitin Gadkari  • India's private sector growth surges to 4-month high in Dec: Report 
Last updated: 04 Jul, 2017  

Bajaj Finance Witnesses Growth in the Professional Loan Segment

Business Wire India | 03 Jul, 2017
Bajaj Finance Ltd, one of the fastest growing financial services company in India, has reported a 55% robust growth in its Doctor Loans segment. Part of its professional loans portfolio, the segment saw a significant jump to Rs 148 crore in March 2017, from Rs 95 cr crore in September 2016. Its online disbursal, which accounts for 25% of the total disbursement, doubled to Rs 16.47 crore from Rs 8.65 crore in the same six-month period.
 
In India, the doctor loans segment is valued at Rs 500 crore of monthly disbursals, of which Bajaj Finance Ltd enjoys an impressive 35% market share. The company, which is the lending arm of Bajaj Finserv Ltd, is now targeting growth by 70% in the doctor loans segment in FY17-18. Bajaj Finance Ltd’s Professional Loan segment registered a growth of 56% in FY17 over the previous year having disbursed Rs 424 crores in Q4 of FY17. The company also increased its geographic spread in the segment from 115 to 140 locations. The overall professional loans segment comprises of Doctors, Chartered Accountants and Engineers and is valued at Rs 750 crore.
 
Under Doctor Loans, the largest sub-segment consists of Doctors who have completed their Post-Graduation and account for 33% of the total loans disbursed to the larger category of Doctors. The next largest sub-segment is of MBBS doctors, accounting for a little over 37 % followed by Dentists with a 17% share.
 
The data also highlights that in terms of experience, Doctors with 10-15 years of practise have 23% share that constitutes the largest chunk of the whole Doctor Loans segment followed by Doctors with over 20 years of experience. The factor that makes this product a unique proposition is the ‘Line of Credit’ offered exclusively by Bajaj Finance Ltd, which is an industry first offering, tailored for professionals. This empowers the doctors availing the loan to manage their cash flows smartly and more efficiently.
 
The product is designed with the thought that loans to doctors are better left flexible considering the dynamic and variable funding requirements they have. The ‘Line of Credit’ ensures that doctors get a dedicated credit line for a particular duration. Throughout this duration, the doctors only repay the interest component of the amount used. The monthly EMI for Line of Credit will only contain the interest amount. The principal amount of the loan has to be paid only when this fixed tenure ends. There will be no principal component on a monthly basis. Bajaj Finance has a holistic product proposition for the doctor community, ranging from unsecured loans (of up to Rs 30 lacs) to secured loans up to Rs 3 Cr.
 
Doctors can avail loans up to Rs 30 lakh, which is the highest loan amount offered by any online provider in the country. Additionally, they need not provide any guarantors or collaterals to avail this loan. They also get a choice of flexible repayment tenors – ranging from 12 months to 60 months. The average ticket size for Doctor loans is Rs 10 lakh.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
84.35
82.60
UK Pound
106.35
102.90
Euro
92.50
89.35
Japanese Yen 55.05 53.40
As on 12 Oct, 2024
  Daily Poll
Will the new MSME credit assessment model simplify financing?
 Yes
 No
 Can't say
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter